ASRGL1: Difference between revisions

Jump to navigation Jump to search
m (→‎Function: Typo/general fixes, replaced: the the → the using AWB)
 
 
Line 3: Line 3:


== Function ==
== Function ==
The ASRGL1 protein consists of 308 amino acids and is activated by autocleavage at amino acid 168 to form an alpha- and a beta-chain, which can dimerize into a heterodimer.<ref>{{Cite journal|last=Li|first=Wenzong|last2=Cantor|first2=Jason R.|last3=Yogesha|first3=S. D.|last4=Yang|first4=Shirley|last5=Chantranupong|first5=Lynne|last6=Liu|first6=June Qingxia|last7=Agnello|first7=Giulia|last8=Georgiou|first8=George|last9=Stone|first9=Everett M.|date=2012-11-16|title=Uncoupling Intramolecular Processing and Substrate Hydrolysis in the N-Terminal Nucleophile Hydrolase hASRGL1 by Circular Permutation|url=http://dx.doi.org/10.1021/cb300232n|journal=ACS Chemical Biology|volume=7|issue=11|pages=1840–1847|doi=10.1021/cb300232n|issn=1554-8929}}</ref> The ASRGL1 enzyme has both L-asparaginase and beta-aspartyl peptidase activity and may be involved in the production of L-aspartate, which can act as an excitatory neurotransmitter in some brain regions.
The ASRGL1 protein consists of 308 amino acids and is activated by autocleavage at amino acid 168 to form an alpha- and a beta-chain, which can dimerize into a heterodimer.<ref>{{Cite journal|last=Li|first=Wenzong|last2=Cantor|first2=Jason R.|last3=Yogesha|first3=S. D.|last4=Yang|first4=Shirley|last5=Chantranupong|first5=Lynne|last6=Liu|first6=June Qingxia|last7=Agnello|first7=Giulia|last8=Georgiou|first8=George|last9=Stone|first9=Everett M.|date=2012-11-16|title=Uncoupling Intramolecular Processing and Substrate Hydrolysis in the N-Terminal Nucleophile Hydrolase hASRGL1 by Circular Permutation|url=https://dx.doi.org/10.1021/cb300232n|journal=ACS Chemical Biology|volume=7|issue=11|pages=1840–1847|doi=10.1021/cb300232n|issn=1554-8929|pmc=3514461}}</ref> The ASRGL1 enzyme has both L-asparaginase and beta-aspartyl peptidase activity and may be involved in the production of L-aspartate, which can act as an excitatory neurotransmitter in some brain regions.


According to antibody-based profiling and transcriptomics analysis, ASRGL1 protein is present in all analysed human tissues, with highest expression in female tissues such as the [[Cervix|uterine cervix]] and [[fallopian tube]], and in male tissues ASRGL1 is highest expressed in the [[Testicle|testis]].<ref>{{Cite web|url=https://www.proteinatlas.org/ENSG00000162174-ASRGL1/tissue|title=Tissue expression of ASRGL1 - Summary - The Human Protein Atlas|website=www.proteinatlas.org|access-date=2017-10-03}}</ref> Based on [[confocal microscopy]] ASRGL1 is mainly localized to the [[microtubule]]s.<ref>{{Cite web|url=https://www.proteinatlas.org/ENSG00000162174-ASRGL1/cell|title=Cell atlas - ASRGL1 - The Human Protein Atlas|website=www.proteinatlas.org|access-date=2017-10-03}}</ref>
According to antibody-based profiling and transcriptomics analysis, ASRGL1 protein is present in all analysed human tissues, with highest expression in brain, in female tissues such as the [[Cervix|uterine cervix]] and [[fallopian tube]], and in male tissues as [[Testicle|testis]].<ref>{{Cite web|url=https://www.proteinatlas.org/ENSG00000162174-ASRGL1/tissue|title=Tissue expression of ASRGL1 - Summary - The Human Protein Atlas|website=www.proteinatlas.org|access-date=2017-10-03}}</ref> Based on [[confocal microscopy]] ASRGL1 is mainly localized to the [[microtubule]]s.<ref>{{Cite web|url=https://www.proteinatlas.org/ENSG00000162174-ASRGL1/cell|title=Cell atlas - ASRGL1 - The Human Protein Atlas|website=www.proteinatlas.org|access-date=2017-10-03}}</ref>


== Clinical significance ==
== Clinical significance ==

Latest revision as of 16:48, 3 January 2019

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

L-asparaginase is an enzyme that in humans is encoded by the ASRGL1 gene.[1]

Function

The ASRGL1 protein consists of 308 amino acids and is activated by autocleavage at amino acid 168 to form an alpha- and a beta-chain, which can dimerize into a heterodimer.[2] The ASRGL1 enzyme has both L-asparaginase and beta-aspartyl peptidase activity and may be involved in the production of L-aspartate, which can act as an excitatory neurotransmitter in some brain regions.

According to antibody-based profiling and transcriptomics analysis, ASRGL1 protein is present in all analysed human tissues, with highest expression in brain, in female tissues such as the uterine cervix and fallopian tube, and in male tissues as testis.[3] Based on confocal microscopy ASRGL1 is mainly localized to the microtubules.[4]

Clinical significance

ASRGL1 is highly expressed in the normal endometrium and differentially expressed in endometrial cancer. Loss of ASRGL1 expression is an unfavorable prognostic feature for patients with endometrial cancer.[5][6]

References

  1. "Entrez Gene: ASRGL1 asparaginase like 1".
  2. Li, Wenzong; Cantor, Jason R.; Yogesha, S. D.; Yang, Shirley; Chantranupong, Lynne; Liu, June Qingxia; Agnello, Giulia; Georgiou, George; Stone, Everett M. (2012-11-16). "Uncoupling Intramolecular Processing and Substrate Hydrolysis in the N-Terminal Nucleophile Hydrolase hASRGL1 by Circular Permutation". ACS Chemical Biology. 7 (11): 1840–1847. doi:10.1021/cb300232n. ISSN 1554-8929. PMC 3514461.
  3. "Tissue expression of ASRGL1 - Summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2017-10-03.
  4. "Cell atlas - ASRGL1 - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2017-10-03.
  5. "Expression of ASRGL1 in endometrial cancer - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2017-10-03.
  6. Edqvist, Per-Henrik D.; Huvila, Jutta; Forsström, Björn; Talve, Lauri; Carpén, Olli; Salvesen, Helga B.; Krakstad, Camilla; Grénman, Seija; Johannesson, Henrik. "Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma". Gynecologic Oncology. 137 (3): 529–537. doi:10.1016/j.ygyno.2015.03.055.

External links

Further reading